Imaging Diagnosis of Primary Liver Cancer Using Magnetic Resonance Dilated Weighted Imaging and the Treatment Effect of Sorafenib

Table 2

General data of patients.

Indicator		Experimental group ()	Control group ()
Age (years)				0.712	0.623
Gender	Males	15	18	—	—
	Females	19	14	—	—
Hepatitis B carriers				0.08	0.99
	Yes	25	26
	No	19	18
HBV replication				3.32	0.28
	Yes	20	23
	No	24	21
Vascular invasion				0.66	0.82
	Yes	21	17
	No	23	27
Distant metastasis				0.33	0.73
	Yes	25	23
	No	19	21
TACE times				0.068	1.03